Skip to content

ROCKWELL MEDICAL, INC.: 10-K filed 2014-03-07

What ROCKWELL MEDICAL, INC. reported in its annual report filed 2014-03-07 (fiscal FY 2013): 36 published measures, 141 facts as tagged in accession 0001047469-14-001989.

This filing

Form
10-K (annual report)
Filed
2014-03-07
Fiscal period
fiscal FY 2013
Accession
0001047469-14-001989 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ROCKWELL MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3136,362,124USD
At 2012-12-3117,025,086USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31595,539USD
At 2012-12-31-9,961,870USD
At 2011-12-3118,244,968USD
At 2010-12-3130,537,937USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3111,881,451USD
At 2012-12-314,711,730USD
At 2011-12-315,715,246USD
At 2010-12-3112,263,449USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-8,332,105USD92
2013-01-01 to 2013-12-31-48,783,312USD365
2013-07-01 to 2013-09-30-13,208,264USD92
2013-04-01 to 2013-06-30-11,863,219USD91
2013-01-01 to 2013-03-31-15,379,724USD90
2012-10-01 to 2012-12-31-13,673,488USD92
2012-01-01 to 2012-12-31-54,021,515USD366
2012-07-01 to 2012-09-30-17,875,775USD92
2012-04-01 to 2012-06-30-11,905,341USD91
2012-01-01 to 2012-03-31-10,566,911USD91
2011-01-01 to 2011-12-31-21,444,557USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-50,664,953USD365
2012-01-01 to 2012-12-31-30,746,844USD366
2011-01-01 to 2011-12-31-10,783,102USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-3170,484,176USD365
2012-01-01 to 2012-12-3118,224,954USD366
2011-01-01 to 2011-12-314,822,834USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-12,649,502USD365
2012-01-01 to 2012-12-3111,518,374USD366
2011-01-01 to 2011-12-31-587,935USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-158,790,569USD
At 2012-12-31-110,007,257USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-01-01 to 2013-12-3132,882,333shares365
2012-01-01 to 2012-12-3120,395,889shares366
2011-01-01 to 2011-12-3117,774,865shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-01-01 to 2013-12-3132,882,333shares365
2012-01-01 to 2012-12-3120,395,889shares366
2011-01-01 to 2011-12-3117,774,865shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2011-01-01 to 2011-12-312,005USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-311,648,949USD
At 2012-12-311,858,442USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-315,849,196USD365
2012-01-01 to 2012-12-314,979,724USD366
2011-01-01 to 2011-12-314,065,703USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-7,529,010USD92
2013-01-01 to 2013-12-31-47,059,266USD365
2013-07-01 to 2013-09-30-12,364,305USD92
2013-04-01 to 2013-06-30-11,775,630USD91
2013-01-01 to 2013-03-31-15,390,321USD90
2012-10-01 to 2012-12-31-13,684,417USD92
2012-01-01 to 2012-12-31-54,262,082USD366
2012-07-01 to 2012-09-30-17,917,934USD92
2012-04-01 to 2012-06-30-11,981,976USD91
2012-01-01 to 2012-03-31-10,677,755USD91
2011-01-01 to 2011-12-31-21,684,757USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3131,917,774USD
At 2012-12-3113,149,432USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-3117,849,671USD
At 2012-12-3126,986,956USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-12-318,686,153USD
At 2012-12-3114,833,565USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2013-12-31920,745USD
At 2012-12-31920,745USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-314,578,319USD
At 2012-12-314,431,932USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-312,799,648USD
At 2012-12-312,649,639USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-312,059,894USD92
2013-01-01 to 2013-12-316,659,220USD365
2013-07-01 to 2013-09-301,633,281USD92
2013-04-01 to 2013-06-301,685,065USD91
2013-01-01 to 2013-03-311,280,980USD90
2012-10-01 to 2012-12-311,702,225USD92
2012-01-01 to 2012-12-316,693,427USD366
2012-07-01 to 2012-09-301,645,927USD92
2012-04-01 to 2012-06-301,718,799USD91
2012-01-01 to 2012-03-311,626,476USD91
2011-01-01 to 2011-12-315,642,910USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-10-01 to 2013-12-313,795,325USD92
2013-01-01 to 2013-12-3114,336,449USD365
2013-07-01 to 2013-09-303,386,367USD92
2013-04-01 to 2013-06-303,237,974USD91
2013-01-01 to 2013-03-313,916,783USD90
2012-10-01 to 2012-12-313,635,386USD92
2012-01-01 to 2012-12-3112,683,860USD366
2012-07-01 to 2012-09-303,325,411USD92
2012-04-01 to 2012-06-302,824,379USD91
2012-01-01 to 2012-03-312,898,684USD91
2011-01-01 to 2011-12-319,522,305USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-10-01 to 2013-12-315,793,579USD92
2013-01-01 to 2013-12-3139,382,037USD365
2013-07-01 to 2013-09-3010,611,219USD92
2013-04-01 to 2013-06-3010,222,721USD91
2013-01-01 to 2013-03-3112,754,518USD90
2012-10-01 to 2012-12-3111,751,256USD92
2012-01-01 to 2012-12-3148,271,649USD366
2012-07-01 to 2012-09-3016,238,450USD92
2012-04-01 to 2012-06-3010,876,396USD91
2012-01-01 to 2012-03-319,405,547USD91
2011-01-01 to 2011-12-3117,805,362USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3140,110,661shares
At 2012-12-3121,494,696shares
At 2011-12-3118,710,002shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-12-3132,419USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-319,765,922USD
At 2012-12-319,310,222USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-318,116,973USD
At 2012-12-317,451,780USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-12-31499,715USD
At 2012-12-31666,744USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-311,374,941USD
At 2012-12-31429,723USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-316,647,828USD
At 2012-12-3112,015,978USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-8,332,105USD92
2013-01-01 to 2013-12-31-48,783,312USD365
2013-07-01 to 2013-09-30-13,208,264USD92
2013-04-01 to 2013-06-30-11,863,219USD91
2013-01-01 to 2013-03-31-15,379,724USD90
2012-10-01 to 2012-12-31-13,673,488USD92
2012-01-01 to 2012-12-31-54,021,515USD366
2012-07-01 to 2012-09-30-17,875,775USD92
2012-04-01 to 2012-06-30-11,905,341USD91
2012-01-01 to 2012-03-31-10,566,911USD91
2011-01-01 to 2011-12-31-21,442,552USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-48,750,893USD365
2012-01-01 to 2012-12-31-53,740,403USD366
2011-01-01 to 2011-12-31-21,512,046USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-12-31840,382USD365
2012-01-01 to 2012-12-31920,368USD366
2011-01-01 to 2011-12-311,141,545USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,007,411USD365
2012-01-01 to 2012-12-311,087,397USD366
2011-01-01 to 2011-12-311,176,007USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31150,009USD365
2012-01-01 to 2012-12-31145,512USD366
2011-01-01 to 2011-12-31-432,751USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-6,147,412USD365
2012-01-01 to 2012-12-319,469,028USD366
2011-01-01 to 2011-12-311,705,030USD365

Inspect the source

Entity
ROCKWELL MEDICAL, INC. / CIK 0001041024
Captured
2026-09-20T05:15:52.429Z
SEC response SHA-256
88e8b83e4e95fda016bcc9a5dced4522c975c40fff65ebdbda5ac42b28ba4fb6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001041024.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))